Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Methylphenidate |
Click to Show/Hide the Detail |
Drug ID |
DR1054
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Bifidobacterium ruminatum co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Methylphenidate |
Click to Show/Hide the Detail |
Drug ID |
DR1054
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Eggerthella lenta co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Bacteroidetes |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Bacteroides thetaiotaomicron further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Bacteroides uniformis further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Enalapril |
Click to Show/Hide the Detail |
Drug ID |
DR0573
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Bacteroides xylanisolvens co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Bacteria: Firmicutes |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Enalapril |
Click to Show/Hide the Detail |
Drug ID |
DR0573
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Blautia hansenii co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Methylphenidate |
Click to Show/Hide the Detail |
Drug ID |
DR1054
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Blautia hansenii co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Methylphenidate |
Click to Show/Hide the Detail |
Drug ID |
DR1054
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Clostridium botulinum co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Clostridium perfringens further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [6] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Enalapril |
Click to Show/Hide the Detail |
Drug ID |
DR0573
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Holdemanella biformis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Lactococcus lactis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Enalapril |
Click to Show/Hide the Detail |
Drug ID |
DR0573
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Lactococcus lactis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [7] |
Streptococcus agalactiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Streptococcus agalactiae further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [6] |
Bacteria: Proteobacteria |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Escherichia coli further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Drug ID |
DR0881
Drug Info
|
Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Escherichia coli co-metabolize the drug Irinotecan hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
|
|
|
|
|
|